Free Trial

Short Interest in Stevanato Group S.p.A. (NYSE:STVN) Decreases By 13.7%

Stevanato Group logo with Medical background

Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) saw a significant drop in short interest in May. As of May 15th, there was short interest totalling 2,710,000 shares, a drop of 13.7% from the April 30th total of 3,140,000 shares. Approximately 5.5% of the company's stock are sold short. Based on an average daily trading volume, of 346,600 shares, the short-interest ratio is currently 7.8 days.

Analysts Set New Price Targets

Several research analysts have recently issued reports on the company. Stephens raised Stevanato Group to a "strong-buy" rating in a research report on Monday, April 21st. William Blair restated an "outperform" rating on shares of Stevanato Group in a research note on Friday, March 7th. Finally, UBS Group dropped their price target on shares of Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research note on Friday, March 7th. Two equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Stevanato Group currently has a consensus rating of "Moderate Buy" and a consensus price target of €25.70 ($29.20).

Read Our Latest Report on STVN

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of STVN. Whittier Trust Co. acquired a new stake in shares of Stevanato Group during the first quarter worth about $27,000. Twin Tree Management LP acquired a new position in Stevanato Group in the 1st quarter valued at about $29,000. Van Berkom & Associates Inc. purchased a new stake in Stevanato Group during the 4th quarter valued at approximately $39,000. Johnson Financial Group Inc. acquired a new stake in Stevanato Group during the 4th quarter worth approximately $41,000. Finally, SVB Wealth LLC acquired a new stake in Stevanato Group during the 1st quarter worth approximately $46,000.

Stevanato Group Stock Performance

Shares of Stevanato Group stock traded up €0.56 ($0.64) on Friday, hitting €23.80 ($27.05). The stock had a trading volume of 290,936 shares, compared to its average volume of 335,964. The stock has a market cap of $7.21 billion, a price-to-earnings ratio of 50.64, a P/E/G ratio of 7.18 and a beta of 0.53. The company has a current ratio of 1.81, a quick ratio of 1.21 and a debt-to-equity ratio of 0.22. Stevanato Group has a 52-week low of €16.56 ($18.82) and a 52-week high of €25.75 ($29.26). The company's 50 day moving average price is €21.94 and its 200 day moving average price is €21.41.

Stevanato Group (NYSE:STVN - Get Free Report) last released its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.23) EPS for the quarter, hitting the consensus estimate of €0.20 ($0.23). The company had revenue of €352.68 million for the quarter, compared to analyst estimates of €346.26 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. On average, research analysts anticipate that Stevanato Group will post 0.5 EPS for the current year.

Stevanato Group Increases Dividend

The firm also recently declared an annual dividend, which will be paid on Thursday, July 17th. Investors of record on Thursday, June 5th will be paid a dividend of $0.0613 per share. The ex-dividend date is Thursday, June 5th. This represents a yield of 0.3%. This is a boost from Stevanato Group's previous annual dividend of $0.05. Stevanato Group's dividend payout ratio is currently 11.76%.

About Stevanato Group

(Get Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Featured Stories

Should You Invest $1,000 in Stevanato Group Right Now?

Before you consider Stevanato Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.

While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines